Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5M | $5.5M | $6.8M | $10.6M | $17.0M | $2.0M |
| Gross profit | −$2.3M | −$1.0M | $457,000 | $1.1M | $1.3M | $902,000 |
| Gross margin | −51.88% | −18.22% | 6.74% | 10.72% | 7.42% | 46.09% |
| Research & development | $217,000 | $642,000 | $853,000 | $476,000 | $419,000 | $348,000 |
| Operating expenses | $4.5M | $6.9M | $7.8M | $8.6M | $17.7M | $620,000 |
| Operating income | −$6.8M | −$7.9M | −$7.4M | −$7.5M | −$16.5M | $282,000 |
| Operating margin | −150.88% | −142.68% | −108.78% | −70.17% | −96.56% | 14.41% |
| EBITDA | −$5.4M | −$6.3M | −$6.0M | −$5.8M | −$16.1M | $365,000 |
| EBITDA margin | −119.26% | −112.83% | −88.90% | −54.55% | −94.75% | 18.65% |
| Net income | −$6.5M | −$5.9M | −$6.1M | −$8.8M | −$16.7M | $403,000 |
| Net profit margin | −142.72% | −106.19% | −90.32% | −83.15% | −98.04% | 20.59% |
| Basic EPSper basic share | -$3.51 | -$3.46 | -$3.79 | -$6.72 | -$1.43 | — |
| Diluted EPSper diluted share | -$3.51 | -$3.46 | -$3.79 | -$6.72 | -$1.43 | — |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
UBS Group AG | 991 |
MORGAN STANLEY | 1 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.